Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia

BACKGROUND: Mixed lineage leukemia (MLL) gene translocations are found in ~75 % infant and 10 % adult acute leukemia, showing a poor prognosis. Lysine-specific demethylase 1 (LSD1) has recently been implicated to be a drug target for this subtype of leukemia. More studies using potent LSD1 inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zizhen, Yao, Yuan, Zhou, Chao, Chen, Fengju, Wu, Fangrui, Wei, Liping, Liu, Wei, Dong, Shuo, Redell, Michele, Mo, Qianxing, Song, Yongcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789278/
https://www.ncbi.nlm.nih.gov/pubmed/26970896
http://dx.doi.org/10.1186/s13045-016-0252-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789278/
https://www.ncbi.nlm.nih.gov/pubmed/26970896
http://dx.doi.org/10.1186/s13045-016-0252-7

Ejemplares similares